Results 41 to 50 of about 2,705 (182)

A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children. [PDF]

open access: yes, 2010
BACKGROUND: The emergence of drug resistant typhoid fever is a major public health problem, especially in Asia. An oral single dose typhoid vaccine would have major advantages.
Schultsz, C   +162 more
core   +1 more source

The Design and Analysis of Seroefficacy Studies for Typhoid Conjugate Vaccines [PDF]

open access: yesClinical Infectious Diseases, 2019
AbstractBackgroundDemonstrating the efficacy of new Vi-conjugate typhoid vaccines is challenging, due to the cost of field trials requiring tens of thousands of participants. New trial designs that use serologically defined typhoid infections (seroefficacy trials) rather than blood culture positivity as a study endpoint may be useful to assess efficacy
Liu, X, Pitzer, V, Pollard, A, Voysey, M
openaire   +3 more sources

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report

open access: yesBMC Pediatrics, 2020
Background Typhoid fever caused by Salmonella enteric serovar Typhi (S. Typhi) is a common cause of morbidity in the world. In 2017, 14.3 million cases of Typhoid and paratyphoid fever occurred globally.
Bernie Endyarni Medise   +12 more
doaj   +1 more source

Target identification for prevention and therapy of "Salmonella" infections [PDF]

open access: yes, 2014
In this thesis we investigated maintenance requirements of Salmonella during chronic infections, and determined the relevant antigen properties that might facilitate the development of Salmonella vaccines. Overall, we wanted to achieve two goals: a)To
Barat, Somedutta
core   +1 more source

Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study

open access: yesEClinicalMedicine, 2020
Background: Typhoid causes significant mortality among young children in resource-limited settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths, but only one WHO-prequalified typhoid conjugate vaccine exists for ...
Maria Rosario Capeding   +24 more
doaj   +1 more source

A Salmonella Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination

open access: yesMicroorganisms, 2021
Vi-polysaccharide conjugate vaccines are efficacious against typhoid fever in children living in endemic settings, their recent deployment is a promising step in the control of typhoid fever.
Elizabeth Jones   +5 more
doaj   +1 more source

Characteristics of the children approached for participation in typhoid conjugate vaccine (TCV) coverage survey.

open access: yes, 2023
Characteristics of the children approached for participation in typhoid conjugate vaccine (TCV) coverage survey.
Sonia Qureshi (6940871)   +8 more
core   +1 more source

A Study on Longevity of Immune Response after Vaccination with Salmonella Typhi Vi Conjugate Vaccine (Pedatyph™) in Children [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Background and Objectives: Owing to the limitations of the conventional polysaccharide vaccines, global efforts have been made to develop conjugated polysaccharide vaccines for typhoid. Duration of immune response induced by these vaccines is critical
Balaji Chinnasami   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy